Clinical Trials Logo

Filter by:
NCT ID: NCT06296862 Not yet recruiting - Heart Failure Clinical Trials

Effect of DASH on HF Outcomes Heart Failure Status in Older Adults (DASH HF)

Start date: March 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effect of the Dietary Approaches to Stop Hypertension (DASH) diet has on heart failure status in older adults. This study is important because it may provide a low-cost strategy to help reduce hospitalizations and deaths for heart failure patients. Participants will be adults age 65 and older with heart failure. They will have 4 study visits, each lasting about 2 hours, and will be in the study for 12 weeks. They will also be asked about their dietary consumption 6 times, each time lasting about 45 minutes. All in-person study visits will take place in the Emory GCRC. Participants will have physical exams, body measurements, blood tests, urinalysis, chart review, and answer surveys. They will be randomized to eat only the DASH diet provided to them for 4 weeks either at the beginning or end of their participation in the study. Participants will be recruited from heart failure patients at Emory University Hospital, Emory University Hospital Midtown, and Emory Outpatient Advanced Heart Failure Therapy Center. The total enrollment planned under Emory's oversight, accounting for screen failures and withdrawals, will be n=38 participants. The study team will obtain informed consent prior to the first study visit either in person, or, alternatively, over the phone, if requested by participants. Specimens and data obtained in this study will not be banked for future use.

NCT ID: NCT06296836 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 2

Effect of Continuing Versus Holding Metformin During Hospitalizations.

Start date: April 1, 2024
Phase: Phase 4
Study type: Interventional

A randomized study of continuing versus holding metformin during hospitalizations to internal medicine services to determine the effects on glucose control, acidosis, abdominal symptoms, length of stay, and mortality.

NCT ID: NCT06296628 Not yet recruiting - Stroke Clinical Trials

Rehabilitation Device for Hand Mirror Therapy

Start date: March 2024
Phase: N/A
Study type: Interventional

This study is a randomized and open comparative study that uses two parallel groups: a control group training with conventional therapy and another group that trains with the device "Miraπ". The participants are patients with stroke with motor weakness in one hand. Two measurement visits are required. During those visits, different hand function assessments will be carried out to analyze the motor function of the subjects hand. The measurements will be done during their inpatient rehabilitation stay, one at time of admission and the second at discharge, each taking 20 minutes. In the time between the measurement visits, the hand therapy takes place fivemtimes a week.

NCT ID: NCT06296589 Not yet recruiting - Clinical trials for Stress Disorders, Post-Traumatic

Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure

PORT
Start date: June 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if receiving Trauma-Informed Guilt Reduction (TrIGR) Therapy is as effective as receiving Prolonged Exposure Therapy among veterans with PTSD and trauma related guilt. The main questions it aims to answer are: Will TrIGR be comparable to PE in terms of PTSD symptom reduction? Will it TrIGR be comparable to PE in improving functioning and reducing depression symptoms? Will it be superior in improving trauma-related guilt and shame?

NCT ID: NCT06296550 Not yet recruiting - Diabetes Type 2 Clinical Trials

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

NCT ID: NCT06296368 Not yet recruiting - Multiple Myeloma Clinical Trials

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

DISCOVERY
Start date: September 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.

NCT ID: NCT06296355 Not yet recruiting - Health Behavior Clinical Trials

Impacts of Warning Labels on Ultra-Processed Foods

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Purpose: The overall purpose of this study is to identify the impacts of an ultra-processed (UPF) health warning label and UPF identify warning label compared to a control label (i.e., a barcode). Participants: ~4,000 US Latino adults of parental age (18-55 years), approximately 50% of whom will have limited English proficiency, recruited from a Latino-focused panel company. Procedures: Participants will be randomly assigned to view food products with one of three label types: health warning labels, identity labels, or barcode control labels. Participants will be asked a series of questions about the products and the label they were assigned.

NCT ID: NCT06296342 Not yet recruiting - Diet, Healthy Clinical Trials

Message Framing and Policy Support for Front-of-package Labeling

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

This study aims to assess whether different message framing about front-of-package labeling policies elicits more policy support than the control (no framing) among Latino and limited English proficiency populations. The study also seeks to identify which message framing elicits the most policy support.

NCT ID: NCT06296186 Not yet recruiting - Clinical trials for Substance Use Disorders

Massed Prolonged Exposure for PTSD in Substance Use Treatment

PREVAIL
Start date: May 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if receiving Prolonged Exposure Therapy for PTSD in massed format (multiple sessions weekly) is as effective as receiving it with sessions once per week among veterans with PTSD and substance use disorder in intensive outpatient substance use treatment. The main questions it aims to answer are: - Will the massed format help participants complete and benefit from Prolonged Exposure in terms of PTSD symptoms? - Will it help participants reduce substance use? Participants who are in intensive substance use treatment will be asked to complete Prolonged Exposure with either weekly sessions or multiple sessions per week.

NCT ID: NCT06295588 Not yet recruiting - Inflammation Clinical Trials

Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

Start date: July 15, 2024
Phase: N/A
Study type: Interventional

To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation.